Status:
RECRUITING
Evaluation of U-AKIpredTM for Predicting AKI in Critically Ill Patients Within 12 Hours: a Multicenter Prospective Cohort Study
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
External Effectiveness Validation of Model
Eligibility:
All Genders
18+ years
Brief Summary
The goal of our study is to evaluate U-AKIpredTM for predicting AKI in critically ill patients within 12 h by the multicenter prospective cohorts. AKI was diagnosed by Kidney Disease Improving Global ...
Eligibility Criteria
Inclusion
- critically ill patients who stayed in ICU for over 24 h;
- patients older than 18 years of age.
Exclusion
- patients who admitted in ICU had been diagnosed acute kidney injury;
- patients who admitted in ICU had been diagnosed acute kidney disease;
- patients who admitted in ICU had been diagnosed chronic kidney disease;
- patients who admitted in ICU had performed kidney dialysis;
- patients who admitted in ICU had performed kidney transplantation;
- Pregnant women.
Key Trial Info
Start Date :
June 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
2100 Patients enrolled
Trial Details
Trial ID
NCT06496555
Start Date
June 1 2024
End Date
December 31 2025
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China